There are also potential therapeutic options regarding nutritional state and muscle wasting that have been tested in patients with HF and have shown beneficial clinical effects in relation to cachexia and sarcopenia, such as beta-blockers, angiotensin-converting-enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs). The gene discussed is ACE; the disease is sarcopenia.